Abstract Lysinuric protein intolerance (LPI; MIM 222700) is an inherited aminoaciduria with an autosomal recessive mode of inheritance. Biochemically, affected patients present with increased excretion of the cationic amino acids: lysine, arginine, and ornithine. We report the first case of LPI diagnosed in Malaysia presented with excessive excretion of homocitrulline. The patient was a 4-year-old male who presented with delayed milestones, recurrent diarrhea, and severe failure to thrive. He developed hyperammonemic coma following a forced protein-rich diet. Plasma amino acid analysis showed increased glutamine, alanine, and citrulline but decreased lysine, arginine and ornithine. Urine amino acids showed a marked excretion of lysine and ornithine together with a large peak of unknown metabolite which was subsequently identified as homocitrulline by tandem mass spectrometry. Molecular analysis confirmed a previously unreported homozygous mutation at exon 1 (235 G>A, p.Gly79Arg) in the SLC7A7 gene. This report demonstrates a novel mutation in the SLC7A7 gene in this rare inborn error of diamino acid metabolism. It also highlights the importance of early and efficient treatment of infections and dehydration in these patients. Conclusion: The diagnosis of LPI is usually not suspected by clinical findings alone, and specific laboratory investigations and molecular analysis are important to get a definitive diagnosis.
Introduction
Lysinuric protein intolerance (LPI; MIM 222700) is an inherited aminoaciduria caused by a defective cationic amino acid transport at the basolateral membrane of epithelial cells in the intestine and kidney [8] . Mutations in the SLC7A7 gene which encodes the y + LAT-1 protein have been found to be responsible for this transport defect [8] . Finland, Southern Italy, and northern Japan have a high prevalence of these cases [7] . Clinically, patients may present with a variety of phenotypic changes ranging from near normal growth with minimal protein intolerance to severe cases with growth delay, hepatosplenomegaly, alveolar proteinosis, osteoporosis [3] , and muscular hypotonia [7] . Biochemically, urinary excretion of lysine is hugely increased with moderate excretion of arginine and ornithine. Plasma concentrations of these dibasic amino acids are usually low but sometimes can be within the normal range [3] . Review of the literature revealed only two descriptions of homocitrullinuria in LPI patient [1, 2] . Here, we report the clinical, biochemical, and molecular findings in a child with LPI who had significant homocitrulline excretion in the urine.
Case history
The patient was a 4-year-old boy who was born at term after an uneventful pregnancy and delivery with birth weight of 2.87 kg. Antenatal history and the neonatal period were unremarkable. He was the eldest of the three siblings. Parents were non-consanguineous but originated from the same village. He had delayed developmental milestones and had recurrent diarrhea, chest infection, and severe failure to thrive since infancy. He could sit without support and started to walk at 19 months. He had frequent falls upon walking unaided at 2 years of age. At the age of 3.5 years old, he presented with lower limb weakness and loss of bladder and bowel control. He was diagnosed as having transverse myelitis and was treated with corticosteroid which resulted in clinical recovery.
He presented again at the age of 4 years old with another episode of diarrhea and vomiting and was noted to be severely malnourished. On clinical assessment, his weight was 8.5 kg (<−4 SD), height 71 cm (<−4 SD), and occipitofrontal circumference 46 cm (−3 SD). He was found to have thin hair, pallor, kyphosis, mild hepatomegaly, muscular hypotonia, and unsteady gait. A high-protein diet was prescribed for him, and this had resulted in altered sensorium. Subsequently, he became comatose and required mechanical ventilation. MRI of the brain was done and showed severe brain atrophy (Fig. 1a) . At this point, a metabolic screening was done (Table 1) . X-ray of the spine and hand showed severe osteopenia and delayed bone age (Fig. 1b, c) . Chest X-ray was reported normal. His younger sister also had history of recurrent diarrhea and was admitted to hospital at 8 months of age. She became drowsy and comatose after feeding with a high-protein diet and unfortunately passed away a few days later.
Materials and method
Urine and plasma for amino acid were analyzed using cation-exchange chromatography by dedicated amino acid analyzer. Urine orotic acid was analyzed using a reverse phase HPLC system. Two milliliters of urine blotted on Whatmann 903 filter paper was sent to the laboratory for confirmation of the homocitrulline by tandem mass spectrometry using the method described by Pitt et al. [4] . DNA was isolated from peripheral blood lymphocytes by standard methods. Polymerase chain reaction amplification and direct sequencing of all coding exons including the flanking intronic regions of the SLC25A15 (ORNT1, chrom. 13q14) and SLC7A7 genes were performed. We proceeded with mutation analysis of the SLC7A7 genes of the parents sample in our molecular laboratory.
Results

Biochemical studies
Plasma amino acids showed marked elevation of glutamine at 1,017 μmol/L (reference range 86-567) and alanine at 1,086 μmol/L (reference range 91-560) with mild elevation of citrulline at 77 μmol/L (reference range 3-42). Plasma ornithine, arginine, and lysine were low at 22 μmol/L Bone age of the fingers and carpals were 1.6 years, whereas bone age of the radius was 2.8 years (reference range 27-96), <1 μmol/L (reference range 14-140), and 73 μmol/L (reference range 85-256), respectively. Urine amino acids showed generalized aminoaciduria with marked elevation of lysine, 967 mmol/mol creatinine (reference range 10-68), and moderate elevation of ornithine, 51 mmol/mol creatinine (reference range <7), but normal arginine, 2 mmol/mol creatinine (reference range <7). There was no argininosuccinic aciduria detected. A large unknown peak was found which was later identified as homocitrulline, 206 mmol/mol creatinine (reference range <10). Urine orotic acid quantified by reverse phase HPLC was 2,147 mmol/mol creatinine (reference range <3.3).
Molecular study
Mutation analysis of SLC25A15 gene did not identify a pathogenic mutation. Mutation analysis of the SLC7A7 gene revealed that the patient was homozygous for a mutation at exon 1: c.235 G>A (p.Gly79Arg), whereas heterozygous mutation at the same site was found in both parents. In a comprehensive review on the mutations in SLC7A7, Sperandeo et al. [8] has described 43 different mutations of SLC7A7 which did not include this patient's mutation.
Discussion
LPI is an autosomal recessive disorder with great phenotypic variations and poor genotype-phenotype correlation. Biochemically, LPI is characterized by excessive renal excretion of lysine and moderate excretion of ornithine and arginine in urine together with poor intestinal absorption [6] which leads to low plasma levels of lysine, arginine, and ornithine. Deficiencies of these urea cycle intermediates cause a malfunction of the urea cycle in LPI [7] . It has also been observed that plasma concentration of neutral amino acids such as serine, glycine, citrulline, proline, alanine, and glutamine may also be increased in these patients [3] . The ingestion of moderate to high protein meals in patients with LPI has been observed to cause episodic hyperammonemia and orotic aciduria [6] . Patients with LPI usually present during the weaning period after the introduction of formula or cow's milk. Patients may present with protein intolerance and growth delay, respiratory symptoms, osteoporosis, and hepatosplenomegaly [7] . The majority of patients have normal intelligence, although few patients were found to have mental retardation [6] . In our patient, the initial clinical suspicion of urea cycle disorder was based on the history of protein intolerance, failure to thrive, and growth delay. The initial biochemical findings, elevated plasma ammonia with marked elevation of urine orotic acid and glutamine, were suggestive of an underlying enzyme deficiency of the urea cycle. The mildly raised plasma citrulline with elevated alanine and low arginine was suspicious of argininosuccinic acid lyase deficiency but was later excluded due to the absence of argininosuccinic aciduria. Oyanagi et al. has showed that patients with LPI has significant marked increased in urinary excretion rates and impairment of intestinal absorption of lysine compared to control subjects following oral loading of L-lysine HCL [2] . They also found that the urinary excretion rates of homocitrulline in LPI were 10 to 15 times higher than the control [2] . The urea cycle malfunction in LPI has been compared with HHH syndrome, and in both conditions, the blockage of the urea cycle produces accumulation of carbamyl phosphate that results in the formation of orotic acid in the cytosol by carbamylation of aspartate and of homocitrulline by carbamylation of lysine [7] .
Samples taken from our patient during periods of hyperammonemia at 4 and 5 years showed increased in both urine orotic acid and homocitrulline (Table 1) , indicating significant accumulation of carbamyl phosphate. Homocitrullinuria has been considered a characteristic of HHH syndrome which originally led us to consider this diagnosis. However, the biochemical abnormalities in this patient illustrate that it may be preferable to think of homocitrullinuria as a relatively non-specific finding in disorders affecting the urea cycle.
Long-term treatment of LPI consists of dietary protein restriction, nitrogen scavenger drugs, and supplementation with citrulline and lysine [5] . In our patient, he was given feeding via gastrostomy, and the dietary protein intake was restricted to 1.5 g/kg/day. He also received oral sodium benzoate 175 mg/kg/day, sodium phenylbutyrate 175 mg/kg/day, citrulline 250 mg/kg/day, arginine 350 mg/kg/day, vitamins, and calcium supplements. Biochemical and clinical improvements were minimal, and compliance was an issue (Table 1) . He died at 6 years of age when there was a delay in seeking medical treatment following an episode of diarrhea. It is likely that this patient's younger sister also had LPI given the similarities in her clinical course. Unfortunately, no material was available to confirm the diagnosis in his sister. The fatal course in these two siblings underlines the importance of aggressive treatment during periods of metabolic decompensation and careful monitoring of protein intake.
Conclusion
The diagnosis of LPI is usually not suspected by clinical findings alone, and specific laboratory investigations and molecular analysis are important to get a definitive diagnosis. Early and efficient treatment of infections and dehydration in these patients is crucial to prevent fatality.
